mRNA LECTURE SERIES 2:
Based on the demand and success of the first lecture series, mRNA Victoria and BioMelbourne Network, are pleased to host a second series of four lectures beginning in November 2023 for the Victorian RNA community.
These lectures present an opportunity for global leading specialists in the RNA field to share their knowledge with the local RNA community. The accompanying networking sessions are an opportunity to foster connections between researchers, industry and government to build a connected and collaborative ecosystem in Victoria.
SERIES 2 | LECTURE ONE | The RNA Platform: The Breadth of Possibility Beyond mRNA
The first lecture in Series 2 focuses on the RNA platform and its different modalities beyond mRNA.
RNA is an emerging global modality that promises treatments for previously ‘undruggable’ diseases. While the COVID pandemic proved the efficacy of mRNA vaccines, RNA as a platform technology has broader implications across multiple modalities such as mRNA, anti-sense oligonucleotides, short-interfering RNA, self-amplifying RNA, circular RNA and aptamers. It can also be used to encode other functional biological molecules such as monoclonal antibodies and cytokines.
This lecture will provide an insight into the breadth of the RNA platform potential and the flexibility it provides to target a range of disease types.
Lecture One will include presentations from three speakers followed by a panel and Q&A discussion.
Important note: This event will be recorded but not live streamed. Attendance is in-person only
WHO SHOULD ATTEND?
The intended audience is those that have an interest in understanding the different modalities of RNA and its potential applications, and researchers with a target antigen that might be considering an RNA approach.
Lecture One Details:
Date: Friday 10 November 2023
Time (AEDT):
7:45am: Guest arrival, registration
8:00am: Networking breakfast (executive lounge)
9:00am: Welcome and opening remarks
9:15am: Presentations and Q&A
10:30am: Networking, tea and coffee (executive lounge)
11:00am: Close
Format: In-person only
Venue: International Chamber House, Theatrette, Level 5, 121 Exhibition Street, Melbourne 3000
Facilitator: Associate Professor Misty Jenkins AO, Laboratory Head, Immunology Division, WEHI
Speakers:
Professor Marco Herold, Chief Executive Officer, Olivia Newtown John Cancer Research Institute
Dr Vi Wickramasinghe, Head, RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre
Dr Christopher Wraight, CEO and Director, RAGE Biotech
Host: Jeff Malone, CEO, BioMelbourne Network
REGISTRATION (IN PERSON ONLY)
BioMelbourne Network Members: $0
BioMelbourne Network Non Members: $85
CANCELLATION POLICY
Full refund given up to 7 days prior to the event.
No refunds within 7 days of the event.
About mRNA Victoria
mRNA Victoria is responsible for leading the Victorian Government’s commitment to establish a world-class mRNA and RNA industry in Victoria, by supporting supply chain, research and development for pre and clinical research, commercialisation and manufacturing investments.Its role is to identify key capabilities, gaps, opportunities and lead the Victorian Government’s engagement, investment and partnerships with domestic and international companies, researchers and stakeholders to build RNA capability.
This lecture series is delivered in partnership with mRNA Victoria and the State Government of Victoria